View in EDS HTML Full Text PDF Full Text

664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Outcomes

Saved in:

Bibliographic Details
Title:	664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Outcomes
Authors:	Alexander, Elizabeth¹ (AUTHOR), Schranz, Jennifer¹ (AUTHOR), Das, Anita F² (AUTHOR), Moran, Gregory J³ (AUTHOR), Sandrock, Christian⁴ (AUTHOR), File, Thomas M⁵ (AUTHOR), Gelone, Steven P¹ (AUTHOR)
Source:	Open Forum Infectious Diseases. 2019 Supplement, Vol. 6, pS304-S305. 2p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	23288957
DOI:	10.1093/ofid/ofz360.732